Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 16.32M |
---|---|---|---|---|---|
Net income 2021 | -36M | Net income 2022 | -43M | EV / Sales 2021 | - |
Net cash position 2021 | 46.83M | Net Debt 2022 | 7.08M | EV / Sales 2022 | - |
P/E ratio 2021 |
-6.47
x | P/E ratio 2022 |
-0.37
x | Employees | 10 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.29% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 0.000001 | 0.00% | 1,208 |
24-05-02 | 0.000001 | 0.00% | 105 |
Delayed Quote OTC Markets, May 06, 2024 at 11:41 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 14 | |
+219.77% | 7.44B | |
+7.60% | 1.09B | |
+2.00% | 981M | |
+41.91% | 872M | |
+21.42% | 797M | |
+1.72% | 664M | |
+11.31% | 648M | |
-.--% | 600M | |
+3.61% | 503M |
- Stock Market
- Equities
- NMTRQ Stock